Skip to the page

Data / Drug companies / Yitongbada (shenzhen) International Trade Co., LTD

Yitongbada (shenzhen) International Trade Co., LTD: 6 products in the FDA NDC directory, labeler code 83364

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Yitongbada (shenzhen) International Trade Co., LTD (labeler code 83364) lists 6 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 6 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on May 12, 2026.

The request: Watch Yitongbada (shenzhen) International Trade Co., LTD (FDA labeler code 83364): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
83364
Products in commercial distribution
6
Packages
6
Finished drugs by generic name
4
Prescription products
0
Over the counter products
6
Flagged as original packager
6 of 6 products that carry the flag
Started marketing in the last 12 months
6
Earliest marketing start
January 1, 2026
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Other unapproved drugs466.7%
Over the counter monograph drugs233.3%

Products by type

TypeProductsShare
Over the counter drugs6100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Nicotine337
Tolnaftate199
Lidocaine1216
Menthol1263

Dosage forms

Dosage formProductsShare
Patch466.7%
Cream233.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Healcome Lidocaine Numbing Cream83364-024CreamOver the counter monograph drugsMay 12, 2026
Deep Numbing Cream83364-023CreamOver the counter monograph drugsApril 13, 2026
Sielkin QUIT SMOKING NICOTINE PATCHES 21mg83364-017PatchOther unapproved drugsJanuary 1, 2026
Sielkin QUIT SMOKING NICOTINE PATCHES 14mg83364-016PatchOther unapproved drugsJanuary 1, 2026
Sielkin QUIT SMOKING NICOTINE PATCHES83364-015PatchOther unapproved drugsJanuary 1, 2026
FungiFree Fungal Nail Patches83364-013PatchOther unapproved drugsJanuary 1, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.